Holdings Channel
Home Articles Latest Filings All Funds Stocks Being Bought Stocks Being Sold Insider Buying



Play Video: The Importance of Insider Buying


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
RDUS — Current Quote
Quotes delayed 20 minutes

Email EnvelopeFree RDUS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

RDUS — Performance
More Insider Buying
Other companies seeing insider buying close in time to when the RDUS Insider Buying occurred are:

CBIO Insider Buying
KKR Insider Buying
SI Insider Buying
PSTX Insider Buying
GPP Insider Buying
FUSN Insider Buying
RVAC Insider Buying
EAR Insider Buying
IIPR Insider Buying
ARTL Insider Buying

RDUS insider buying image
The table below summarizes the most recent RDUS insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why RDUS insider buys are important for investors to follow.
DateInsiderPriceAmount
8-11-2022
Insider Buy		 Capital Management LP Rubric
>10% Owner		 $10.07
CAGR » 		$16,907,066.78
1,678,954 shares
8-10-2022
Insider Buy		 Capital Management LP Rubric
>10% Owner		 $10.07
CAGR » 		$40,400.84
4,012 shares
5-18-2022
Insider Buy		 Target N. V. Biotech
>10% Owner		 $5.57
CAGR » 		$2,661,001.86
477,824 shares
1-6-2022
Insider Buy		 Target N. V. Biotech
>10% Owner		 $6.31
CAGR » 		$3,469,060.00
550,000 shares
12-16-2021
Insider Buy		 Capital Management LP Rubric
>10% Owner		 $7.07
CAGR » 		$1,037,752.37
146,685 shares
12-10-2021
Insider Buy		 Capital Management LP Rubric
>10% Owner		 $7.54
CAGR » 		$12,015,791.72
1,593,506 shares
9-29-2021
Insider Buy		 Target N. V. Biotech
>10% Owner		 $12.95
CAGR » 		$1,294,500.00
100,000 shares
9-22-2021
Insider Buy		 Target N. V. Biotech
>10% Owner		 $12.28
CAGR » 		$1,841,280.00
150,000 shares
11-5-2020
Insider Buy		 Target N. V. Biotech
>10% Owner		 $14.26
CAGR » 		$1,426,230.00
100,000 shares
9-14-2020
Insider Buy		 Target N. V. Biotech
>10% Owner		 $11.69
CAGR » 		$2,338,680.00
200,000 shares
9-11-2020
Insider Buy		 Target N. V. Biotech
>10% Owner		 $11.33
CAGR » 		$2,255,117.99
199,029 shares
7-8-2020
Insider Buy		 Target N. V. Biotech
>10% Owner		 $13.21
CAGR » 		$330,177.50
25,000 shares
4-30-2020
Insider Buy		 Target N. V. Biotech
>10% Owner		 $15.75
CAGR » 		$787,555.00
50,000 shares
11-6-2019
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $23.00
CAGR » 		$2,300,300.00
100,000 shares
6-7-2019
Insider Buy		 Joseph Francis Kelly
Sr. VP of Sales and Marketing		 $21.81
CAGR » 		$54,536.00
2,500 shares
5-10-2019
Insider Buy		 Joseph Francis Kelly
Sr. VP of Sales and Marketing		 $21.43
CAGR » 		$42,860.00
2,000 shares
3-5-2019
Insider Buy		 Jessica Hopfield
Director		 $19.23
CAGR » 		$246,190.08
12,800 shares
12-20-2018
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $14.48
CAGR » 		$868,782.00
60,000 shares
12-17-2018
Insider Buy		 Joseph Francis Kelly
Sr. VP of Sales and Marketing		 $15.71
CAGR » 		$47,130.00
3,000 shares
12-14-2018
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $15.64
CAGR » 		$938,256.00
60,000 shares
8-20-2018
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $19.65
CAGR » 		$1,178,808.00
60,000 shares
8-15-2018
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $20.83
CAGR » 		$3,528,409.61
169,363 shares
8-8-2018
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $22.73
CAGR » 		$1,363,884.00
60,000 shares
7-27-2018
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $24.81
CAGR » 		$1,240,605.00
50,000 shares
7-25-2018
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $27.28
CAGR » 		$1,363,805.00
50,000 shares
6-11-2018
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $27.36
CAGR » 		$1,367,835.00
50,000 shares
5-23-2018
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $28.91
CAGR » 		$1,156,320.00
40,000 shares
5-21-2018
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $29.27
CAGR » 		$1,756,380.00
60,000 shares
4-19-2018
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $33.80
CAGR » 		$1,351,936.00
40,000 shares
4-5-2018
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $36.58
CAGR » 		$1,828,845.00
50,000 shares
3-2-2018
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $32.52
CAGR » 		$2,601,448.00
80,000 shares
2-9-2018
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $34.38
CAGR » 		$2,578,762.50
75,000 shares
11-14-2017
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $26.25
CAGR » 		$1,312,390.00
50,000 shares
11-10-2017
Insider Buy		 Brent Hatzis-schoch
Sr. VP, General Counsel		 $28.09
CAGR » 		$49,942.78
1,778 shares
11-7-2017
Insider Buy		 Jesper Hoiland
President and CEO		 $29.04
CAGR » 		$197,450.24
6,800 shares
11-3-2017
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $29.15
CAGR » 		$1,457,575.00
50,000 shares
10-26-2017
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $30.95
CAGR » 		$1,547,550.00
50,000 shares
10-25-2017
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $32.85
CAGR » 		$1,642,415.00
50,000 shares
9-15-2017
Insider Buy		 Jesper Hoiland
President and CEO		 $32.72
CAGR » 		$199,608.47
6,100 shares
9-14-2017
Insider Buy		 Jose Carmona
Chief Financial Officer		 $32.83
CAGR » 		$98,502.90
3,000 shares
9-14-2017
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $33.45
CAGR » 		$5,017,975.00
150,000 shares
9-12-2017
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $35.42
CAGR » 		$1,770,820.00
50,000 shares
9-5-2017
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $36.75
CAGR » 		$1,837,625.00
50,000 shares
8-16-2017
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $35.98
CAGR » 		$2,158,536.00
60,000 shares
8-10-2017
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $34.97
CAGR » 		$5,245,027.50
150,000 shares
5-30-2017
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $34.21
CAGR » 		$1,368,348.00
40,000 shares
5-25-2017
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $36.25
CAGR » 		$1,450,020.00
40,000 shares
5-18-2017
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $34.41
CAGR » 		$1,720,345.00
50,000 shares
5-17-2017
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $33.44
CAGR » 		$1,170,386.60
35,000 shares
5-12-2017
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $34.00
CAGR » 		$509,995.50
15,000 shares
5-9-2017
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $35.93
CAGR » 		$1,796,480.00
50,000 shares
5-8-2017
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $35.57
CAGR » 		$1,543,912.46
43,400 shares
5-2-2017
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $33.91
CAGR » 		$2,542,920.00
75,000 shares
5-1-2017
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $35.39
CAGR » 		$5,308,605.00
150,000 shares
3-21-2017
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $35.83
CAGR » 		$1,791,625.00
50,000 shares
3-17-2017
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $38.41
CAGR » 		$1,152,249.00
30,000 shares
3-15-2017
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $39.97
CAGR » 		$2,466,871.29
61,721 shares
3-10-2017
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $39.17
CAGR » 		$1,499,285.08
38,279 shares
1-25-2016
Insider Buy		 Lorraine A. Fitzpatrick
Chief Medical Officer		 $49.28
CAGR » 		$9,856.50
200 shares
1-22-2016
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $31.67
CAGR » 		$1,211,501.84
38,259 shares
1-13-2016
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $39.90
CAGR » 		$1,994,885.00
50,000 shares
9-14-2015
Insider Buy		 David P. Snow
Chief Commercial Officer		 $69.79
CAGR » 		$418,740.00
6,000 shares
8-31-2015
Insider Buy		 Dinesh Purandare
SVP Global Oncology/Commercial		 $62.20
CAGR » 		$12,440.00
200 shares
8-21-2015
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $64.00
CAGR » 		$6,400,030.00
100,000 shares
7-23-2015
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $74.00
CAGR » 		$18,500,000.00
250,000 shares
5-1-2015
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $36.46
CAGR » 		$1,822,965.00
50,000 shares
4-29-2015
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $36.23
CAGR » 		$1,811,580.00
50,000 shares
4-27-2015
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $38.38
CAGR » 		$1,919,010.00
50,000 shares
4-28-2015
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $36.59
CAGR » 		$1,829,275.00
50,000 shares
3-6-2015
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $47.08
CAGR » 		$3,531,127.50
75,000 shares
2-25-2015
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $45.74
CAGR » 		$1,600,851.00
35,000 shares
6-6-2014
Insider Buy		 Growth N. V. Biotech
>10% Owner		 $8.00
CAGR » 		$8,000,000.00
1,000,000 shares

Also See: Institutional Holders of RDUS
Also See: SEC filings

RDUS Performance Since Insider Purchase
Below we present the annualized performance delivered by RDUS stock since 8-11-2022 (the date of the most recent insider purchase). The performance of the investment from the time RDUS insider buying occurred is the ultimate test of whether insiders were right about RDUS being a good buy.

Growth of $10,000.00
With Dividends Reinvested
Start date: 08/12/2022
End date: 05/10/2024
Start price/share: $37.33
End price/share: $18.39
Starting shares: 267.88
Ending shares: 281.72
Dividends reinvested/share: $1.32
Total return: -48.19%
Average Annual Total Return: -31.40%
Starting investment: $10,000.00
Ending investment: $5,180.26
Years: 1.75
 
Growth of $10,000.00
Without Dividends Reinvested
Start date: 08/12/2022
End date: 05/10/2024
Start price/share: $37.33
End price/share: $18.39
Dividends collected/share: $1.32
Total return: -47.21%
Average Annual Total Return: -30.65%
Starting investment: $10,000.00
Ending investment: $5,279.51
Years: 1.75

RDUS Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent RDUS insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding RDUS

RDUS Insider Buying | www.HoldingsChannel.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.